.
BUDGET 2012
 | News | Market | Portfolio | Messages
S&P BSE SENSEX
27803.24 92.72 (0.33%)
NIFTY 50
8541.20 31.10 (0.37%)
Go to Moneycontrol Home
Pharmaceuticals
Biocon to launch insulin glargine in Malaysia in H2 FY17
The biosimilar product, which is developed and manufactured by Biocon, has already been launched by its partner Fujifilm
Syngene lines up $200 mn capex to boost manufacturing
Wockhardt receives US FDA's establishment inspection report
Suven Life receives Establishment Inspection Report from USFDA
STOCK RECOMMENDATION
Stock Advice
Aurobindo Pharma top pick: Dhananjay Sinha
Tulsian shares his view on Biocon, Bharat Financial & others
Aurobindo Pharma may hit Rs 825, M&M Rs 345: Prakash Gaba
more
Broker Reports
Hold Torrent Pharma; target of Rs 1560: Religare
Buy Jubilant Life; target of Rs 484: Prabhudas Lillader
Hold Alembic Pharma; target of Rs 600: Axis Direct
more
Budget 2012
HOME
Font Size: S M L
Mobile | Classic
Customer Support
© 2011. a Web18 Venture